GRI Bio, Inc.
GRI
$2.31
$0.062.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -35.28% | 56.78% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -20.83% | 16.15% | |||
| Operating Income | 20.83% | -16.15% | |||
| Income Before Tax | 20.84% | -16.15% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 20.84% | -16.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 20.84% | -16.15% | |||
| EBIT | 20.83% | -16.15% | |||
| EBITDA | 20.84% | -16.16% | |||
| EPS Basic | 63.07% | 2.30% | |||
| Normalized Basic EPS | 63.07% | 2.30% | |||
| EPS Diluted | 63.07% | 2.30% | |||
| Normalized Diluted EPS | 63.07% | 2.30% | |||
| Average Basic Shares Outstanding | 114.42% | 18.78% | |||
| Average Diluted Shares Outstanding | 114.42% | 18.78% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||